Metrics
Metrics
Commercial studies at UHDB
The following table displays the recruitment to time and target for commercial studies currently open to recruitment at UHDB.
- Green: studies are recruiting to time and target
- Amber: studies are recruiting within 90% of the current recruitment study target
- Red: studies are recruiting less than 90% of the current recruitment study target
The data cut off for this information was 31/03/2019.
|
Recruitment to Time and Target |
Number of studies |
Percentage of studies |
|---|---|---|
|
Green |
15 |
75% |
|
Amber |
0 |
0% |
|
Red |
5 |
25% |
|
TOTAL |
20 |
100% |
|
Number of Principal Investigators |
15 |
|
|
Recruitment since April 2018 |
107 |
|
Performance of Initiating and Delivering Clinical Trials at UHDB
The table below presents the metrics for clinical trials (Clinical Trials of Investigational Medicinal Product - CTIMPs, Device studies or other type of clinical trial) taking place at UHDB sites based on information we submit every quarter to NIHR. Summary statistics are presented about the number of days between date site selected by the Research Sponsor, date site confirmed and first patient recruited, as well as the percentage of commercial clinical trials recruiting to time to target.
| Metric | Q3 2018-19 | Q2 2018-19 | Q1 2018-19 | National Figure |
|---|---|---|---|---|
| INITIATION (All clinical trials) | ||||
| Number of trials submitted | 25 | 15 | 22 | |
| Date site selected to First Patient recruited mean | 80.7 | 61.9 | 75 | 83.8 |
| Date site selected to date site confirmed | 39.8 | 24.8 | 33.1 | |
| Date site confirmed to first patient recruited | 88.5 | 67.5 | 61.4 | |
| Position in the league | 3rd | 8th | 5th | |
| DELIVERY (Commercial clinical trials only) | ||||
| Trials submitted | 6 | 4 | 5 | |
| % of trials recruiting to time and target | 50% | 50% | 50% | 55.9% |
| Position in league | 13th (out of 27) for trials meeting target | 20th for trials meeting target | 3rd for trials meeting target | |